Neumentum to Participate in Upcoming January Virtual Investor Conferences

MORRISTOWN, NJ, January 5, 2021 – Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer at Neumentum, will present at two upcoming investor conferences in January.